Lymph node staging in prostatic carcinoma revisited

Acta Oncologica

Volumn 44, Issue 6, 2005, Pages 593-598

  Malmström, Per Uno ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; GLEASON SCORE; HUMAN; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CARCINOMA; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PELVIS; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 27144466713     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860510029626     Document Type: Conference Paper

References (37)

1. Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000;31:578-83.
2. Cunéo B, Marcille M. Note sur les lymphatiques de la vessie. Bull Mem Soc Anat 1901;6:649-51.
3. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 1996;156:1969-71.
4. McLaughlin AP, Saltzstein SL, McCullough DL, Gittes RF. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 1976;115:89-94.
5. Golimbu M, Morales P, Al-Askari S, Brown J. Extended pelvic lymphadenectomy for prostatic cancer. J Urol 1979; 121:617-20.
6. Fowler JE Jr, Whitmore WF Jr. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 1981;47:2941-5.
7. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002; 167:1681-6.
8. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167:528-34.
9. Agjertson CJ, Asher P, Sclar JD, et al. Abstract to AUA 2004. J Urol 2004;171:385.
10. Aus G, Abbou CC, Pacik D, Schmid HP, van Poppel H, Wolff JM, Zattoni F, EAU Working Group on Oncological Urology. EAU guidelines on prostate cancer. Eur Urol 2001; 40:97-101.
11. NCCN guidelines. Available online at: http://www.nccn.org/professionals/ physician_gls/PDF/prostate.pdf
12. Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004;171:2122-7.
13. Dimarco DS, Zincke H, Slezac JM, Bergstralh EJ, Blute ML, Rochester MN J. Abstract to AUA. J Urol 2003;169.
14. Clark T, Parekh DJ, Cookson MS, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003;169:1445-7.
15. Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 1997;158:1891-4.
16. Burkhard FC, Bader P, Schneider E, Markwalder R, Studer UE. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 2002;42:84-90.
17. Di Blasio CJ, Fearn P, Song SH, Kattan MW, Scardino PT. Proceedings of the AUA. J Urol 2003;169(Suppl).
18. Bader E, Spahn M, Huber R, et al. Abstract to EAU. 2004. Eur Urol 2004;3:16.
19. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York. Wiley; 1997.
20. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069-77.
21. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 1999;79:1522-30.
22. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-9.
23. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a "sentinel node" in cancer of the parotid. Cancer 1960;13:77-8.
24. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
25. Nieweg OE, Tanis PJ, Kroon BB. The definition of a sentinel node. Ann Surg Oncol 2001;8:538-41.
26. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
27. Keshtgar MRS, Ell PJ. Clinical role of sentinel-lymph-node biopsy in breast cancer. Lancet Oncol 2002;3:105-10.
28. Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003;170:783-6.
29. Sherif A, De La Torre M, Malmstrom PU, Thorn M. Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 2001;166:812-5.
30. Wawroschek F, Vogt H, Wengenmair H, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 2003;70:303-10.
31. Jeschke S, Leeb K, Nambirajan T, et al. Abstract to EAU. E Urol 2004;3:16.
32. Corvin S, Eichorn H, Wurm TM, et al. Abstract to EAU. E Urol 2004;3:549.
33. Janzen NK, Laifer-Narin S, Han KR, et al. Emerging technologies in uroradiologic imaging. Urol Oncol 2003;21: 317-26.
34. Fricke E, Machtens S, Hofmann M, et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging 2003;30:607-11.
35. De Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 2003;44:32-8.
36. Gottfried HW, Bartsch G, Messe PM, et al. 11C-Choline-PET/CT a new image modality in prostate cancer detection. Abstract to AUA. J Urol 2004;171 (Suppl):480.
37. Nilsson S, Norlen BJ, Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 2004;43(4):316-81.